Journal of Hematology & Oncology

official impact factor 2.93

Open Access

RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

Song Dong, Ai-Lin Guo, Zhi-Hong Chen, Zhen Wang, Xu-Chao Zhang, Ying Huang, Zhi Xie, Hong-Hong Yan, Hua Cheng and Yi-Long Wu*

Journal of Hematology & Oncology 2010, 3:10 doi:10.1186/1756-8722-3-10

Accesses  

  • Last 30 days: 77 accesses
  • Last 365 days: 971 accesses
  • All time: 2907 accesses